Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nicholson

Showing results (351-360 of 361) with videos related to

Pageof 37
Sort By:
American Journal of Medical Genetics. Part A|March 11, 2005
Retrospective family study of childhood medulloblastomaDavid Ng, Theodora Stavrou, Ling Liu, et al.
Contemporary Clinical Trials|November 7, 2022
The Preventing Alzheimer's with Cognitive Training (PACT) randomized clinical trialJody S Nicholson, Elizabeth M Hudak, Christine B Phillips, et al.
Cancer|May 15, 1996
Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II studyR J Packer, M Prados, P Phillips, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexMichael S South, Brenda L Case, Rhonda S Wood, et al.
The Journal of Infection|February 8, 2025
Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody responseC C A Noble, E McDonald, S Nicholson, et al.
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Nature Communications|October 11, 2024
Zika viruses encode 5' upstream open reading frames affecting infection of human brain cellsCharlotte Lefèvre, Georgia M Cook, Adam M Dinan, et al.
Journal of Medicinal Chemistry|September 5, 2003
Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexJohn J Parlow, Brenda L Case, Thomas A Dice, et al.
The Journal of Infection|November 16, 2024
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Pageof 37

Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
American Journal of Medical Genetics. Part A|March 11, 2005
Retrospective family study of childhood medulloblastomaDavid Ng, Theodora Stavrou, Ling Liu, et al.
Contemporary Clinical Trials|November 7, 2022
The Preventing Alzheimer's with Cognitive Training (PACT) randomized clinical trialJody S Nicholson, Elizabeth M Hudak, Christine B Phillips, et al.
Cancer|May 15, 1996
Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II studyR J Packer, M Prados, P Phillips, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexMichael S South, Brenda L Case, Rhonda S Wood, et al.
The Journal of Infection|February 8, 2025
Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody responseC C A Noble, E McDonald, S Nicholson, et al.
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Nature Communications|October 11, 2024
Zika viruses encode 5' upstream open reading frames affecting infection of human brain cellsCharlotte Lefèvre, Georgia M Cook, Adam M Dinan, et al.
Journal of Medicinal Chemistry|September 5, 2003
Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexJohn J Parlow, Brenda L Case, Thomas A Dice, et al.
The Journal of Infection|November 16, 2024
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Pageof 37